同位素标记

首页 / 常见产品 / 同位素标记

「同位素标记抑制剂」Nifuroxazide-13C6

  • 产品货号:E-T202508210001
  • 发布时间:2025-08-21
  • 产品CAS :N/A
  • 产品规格:mg
  • 产品纯度:≥95%
  • 产品货期:现货下单后48小时内发货,定制产品4-8周。
  • 运输条件:顺丰常规运输
询价
产品详情

货号:E-T202508210001
CAS:N/A
规格:mg
纯度:≥95%
生产商:试剂家

生物活性:Nifuroxazide-13C6 is the 13C6 labeled Nifuroxazide. Nifuroxazide is an effective inhibitor of STAT3, also exerts potent anti-tumor and anti-metastasis activity.
体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
试剂家 has not independently confirmed the accuracy of these methods. They are for reference only.
Nifuroxazide-13C6 相关抗体:
FOXP3 Antibody (YA858)
Phospho-STAT3 (Tyr705) Antibody (YA146)
STAT3 Antibody (YA056)
Phospho-STAT1 (Ser727) Antibody (YA148)
Phospho-STAT1 (Tyr701) Antibody
Phospho-STAT3 (Tyr705) Antibody
FOXP3 Antibody
Phospho-STAT3 (Ser727) Antibody
STAT1 Antibody (YA059)
STAT1 Antibody (YA667)
STAT1 alpha Antibody
STAT2 Antibody (YA057)
STAT5a Antibody
STAT5b Antibody
STAT6 Antibody
Phospho-STAT5 (Tyr694) Antibody (YA145)
FOXP3 Antibody (YA759)
Phospho-STAT1 (Ser727) Antibody (YA149)
STAT3 Antibody (YA666)
STAT4 Antibody
STAT5 Antibody
MRP2 Antibody
Elongation factor 2 Antibody (YA962)
Elongation factor 2 Antibody (YA964)
PU.1/SPI1 Antibody (YA1116)
Phospho-STAT5(Tyr694) Antibody (YA1513)
Sulfadimidine Antibody (YA906)
Elongation factor 2 Antibody (YA963)
Anthrax Protective gen Antibody (YA1060)
T-bet / Tbx21 Antibody (YA1217)
分子量:281.17
Formula:C613C6H9N3O5
非标记 CAS:965-52-6
中文名称:硝呋齐特-13C6; 硝呋酚酰肼-13C6
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (521 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
 [Content Brief]
[2]. Nelson EA, et al. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. Blood. 2008 Dec 15;112(13):5095-102.
 [Content Brief]
[3]. Zhu Y, et al. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Sci Rep. 2016 Feb 2;6:20253.
 [Content Brief]

常见基团 common groups
Online message

在线留言

欢迎您访问“试剂家 | 纳米靶向科研平台”官方网站,请留下您的需求,我们会派专业人员及时与您联系,并为您提供相应的产品方案。

* 咨询产品
* 您的姓名
* 联系电话
留言内容
验证码
Related Products

相关产品